Meritage Portfolio Management Repligen Corp Transaction History

Meritage Portfolio Management

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 Apr 27, 2021	SELL	$180.37 - $226.26 $423,869 - $531,711	-2,350 Closed	0 $0
Q4 2020 Feb 03, 2021	SELL	$148.08 - $206.57 $11.1 Million - $15.5 Million	-74,965 Reduced 96.96%	2,350 $450,000
Q3 2020 Oct 26, 2020	SELL	$122.51 - $158.27 $23,399 - $30,229	-191 Reduced 0.25%	77,315 $11.4 Million
Q2 2020 Jul 27, 2020	BUY	$94.33 - $140.48 $275,537 - $410,342	2,921 Added 3.92%	77,506 $9.58 Million
Q1 2020 Apr 27, 2020	BUY	$84.96 - $109.14 $6.34 Million - $8.14 Million	74,585 New	74,585 $7.2 Million

488

54.2M

341K

235K

Ticker RGEN
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 55,491,200
Market Cap $8.02B
Description
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....

Get notified when there are updates to the investment portfolio of Meritage Portfolio Management, based on Form 13F filings with the SEC.

Stay updated on Meritage Portfolio Management with notifications on news.